Activities of Daily Living Decrease Serum Levels of C-Reactive Protein in Elderly Adults but Not in Young and Middle-Aged Adults

2016 ◽  
Vol 64 (4) ◽  
pp. 883-884
Author(s):  
Katarzyna Wesolowska ◽  
Bożena Czarkowska-Paczek ◽  
Agnieszka Wirkowska
Keyword(s):  
Activities Of Daily Living ◽  
Daily Living ◽  
Serum Levels ◽  
Elderly Adults ◽  
C Reactive Protein ◽  
Middle Aged ◽  
Reactive Protein ◽  
Middle Aged Adults

scholarly journals C-reactive protein, obesity, atopy and asthma symptoms in middle-aged adults

2008 ◽  
Vol 32 (1) ◽  
pp. 77-84 ◽  
Author(s):  
B. K. Butland ◽  
D. P. Strachan ◽  
A. R. Rudnicka
Keyword(s):  
C Reactive Protein ◽  
Middle Aged ◽  
Reactive Protein ◽  
Asthma Symptoms ◽  
Middle Aged Adults

Abstract T P161: Asymmetric Dimethylarginine, C-reactive Protein, and the Risk of Developing Metabolic Syndrome in Middle-Aged Men

Stroke ◽  
2015 ◽  
Vol 46 (suppl_1) ◽  
Author(s):  
Yasuhiro Nishiyama ◽  
Toshiaki Otsuka ◽  
Masayuki Ueda ◽  
Kazumi Kimura
Keyword(s):  
Metabolic Syndrome ◽  
Asymmetric Dimethylarginine ◽  
Serum Levels ◽  
Cox Proportional Hazards Model ◽  
New Combination ◽  
C Reactive Protein ◽  
Middle Aged ◽  
Reactive Protein ◽  
The Metabolic Syndrome ◽  
Hs Crp

BACKGROUND: The metabolic syndrome has known as an independent risk factor of stroke. We have recently shown that the measurement of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, may be useful for identifying individuals with a high risk of stroke among Japanese population. We aimed to examine whether serum levels of ADMA and a high-sensitivity C-reactive protein (hs-CRP) are associated with the risk of developing metabolic syndrome in middle-aged men. METHODS: In this longitudinal study, serum ADMA and hs-CRP levels were measured in Japanese men without metabolic syndrome, which was diagnosed according to the currently accepted unified criteria. The subjects were followed-up for a maximum of four years to determine new-onset metabolic syndrome. A Cox proportional hazards model with adjusting for potential confounders was applied to determine the hazard ratio (HR) for developing metabolic syndrome according to serum levels of ADMA and hs-CRP, considered either alone or in combination. RESULTS: Of the 848 subjects (mean age, 43 ± 6 years), 100 subjects developed metabolic syndrome. High ADMA levels (≥ 0.45μmol/L) alone did not show a significant HR for developing metabolic syndrome, while high hs-CRP levels (≥ 0.3 mg/L) did (HR 1.82, 95% CI 1.17-2.83). The combination of high levels of both hs-CRP and ADMA had a high HR (2.32, 95% CI 1.30-4.14) as compared to low levels of both markers. In contrast, the HR was not significant in the combination of high hs-CRP and low ADMA levels, as well as low hs-CRP and high ADMA levels. CONCLUSIONS: Serum hs-CRP, but not ADMA, levels were associated with the risk of metabolic syndrome. Furthermore, the combination of high ADMA and high CRP levels increased the risk of metabolic syndrome. Hence, further studies are needed, but measuring the new combination of two markers may potentiate the predictive value for developing cardiovascular diseases including stroke.

scholarly journals Elevated Serum C-Reactive Protein Relates to Increased Cerebral Myoinositol Levels in Middle-Aged Adults

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Danielle E. Eagan ◽  
Mitzi M. Gonzales ◽  
Takashi Tarumi ◽  
Hirofumi Tanaka ◽  
Sandra Stautberg ◽  
...  
Keyword(s):  
Grey Matter ◽  
Cerebral Metabolism ◽  
Elevated Serum ◽  
C Reactive Protein ◽  
Middle Aged ◽  
Blood Draw ◽  
Reactive Protein ◽  
Middle Aged Adults ◽  
Serum Crp ◽  
The Relationship

C-reactive protein (CRP), a systemic marker of inflammation, is a risk factor for late life cognitive impairment and dementia, yet the mechanisms that link elevated CRP to cognitive decline are not fully understood. In this study we examined the relationship between CRP and markers of neuronal integrity and cerebral metabolism in middle-aged adults with intact cognitive function, using proton magnetic resonance spectrocospy. We hypothesized that increased levels of circulating CRP would correlate with changes in brain metabolites indicative of early brain vulnerability. Thirty-six individuals, aged 40 to 60, underwent neuropsychological assessment, a blood draw for CRP quantification, and 1H MRS examining N-acetyl-aspartate, myo-inositol, creatine, choline, and glutamate concentrations in occipito-parietal grey matter. Independent of age, sex and education, serum CRP was significantly related to higher cerebral myo-inositol/creatine ratio (F(4,31)=4.74,  P=0.004), a relationship which remained unchanged after adjustment for cardiovascular risk (F(5,30)=4.356, CRP β = 0.322, P=0.045). Because these biomarkers are detectable in midlife they may serve as useful indicators of brain vulnerability during the preclinical period when mitigating intervention is still possible.

Sign in / Sign up

Export Citation Format

Share Document